The chart below shows the percentage of a drug company’s total sales, by region, from 2002 to 2006.Summarise the information by selecting and reporting the main features, and make comparisons where relevant.

The bar chart illustrates the distribution of a drug company's total

sales

across three regions—

America

,

Europe

, and

Asia

—over a five-year period from 2002 to 2006. The percentages of

sales

in each region are provided for each year. In 2002,

America

accounted for the highest proportion of

sales

at 41%,

while

Europe

and

Asia

contributed 34% and 25%, respectively. Over the years, the percentage of

sales

in

America

gradually decreased to 30% by 2006.

Conversely

,

Europe

maintained a relatively stable

share

, fluctuating slightly between 35% and 38%.

Asia

,

however

, experienced a steady increase in its

share

of

sales

, rising from 25% in 2002 to 40% in 2006.

This

increase made

Asia

the region with the highest

sales

percentage by the end of the period, surpassing both

America

and

Europe

. Notably,

while

America

’s

share

showed a consistent decline,

Europe

’s

share

did not experience significant changes.

Overall

, the data indicates a shift in the drug company’s

sales

distribution, with

Asia

becoming the most significant market by 2006,

while

America

's contribution steadily decreased.